UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 771

Sortiert nach

Personalized cancer medicine and the future of pathology

Virchows Archiv : an international journal of pathology, 2012, Vol.460 (1), p.3-8

2012

Volltextzugriff (PDF)

Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons

Infection, 2009-10, Vol.37 (5), p.390-400

2009

Volltextzugriff (PDF)

Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial

Annals of oncology, 2007-09, Vol.18 (9), p.1493-1499

2007

Volltextzugriff (PDF)

Trastuzumab beyond progression: a cost-utility analysis

Annals of oncology, 2010-11, Vol.21 (11), p.2161-2168

2010

Volltextzugriff (PDF)

Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective

Journal of human hypertension, 2010-02, Vol.24 (2), p.117-123

2010

Volltextzugriff (PDF)

Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review

Journal of thrombosis and haemostasis, 2006-06, Vol.4 (6), p.1180-1185

2006

Volltextzugriff (PDF)

Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients with Cancer- or Chemotherapy-Induced Anemia

Oncology, 2011-01, Vol.81 (1), p.45-49

2011

Volltextzugriff (PDF)

Pharmacogenetic information in Swiss drug labels - a systematic analysis

The pharmacogenomics journal, 2021-08, Vol.21 (4), p.423-434

2021

Volltextzugriff (PDF)

The economic burden of asthma: direct and indirect costs in Switzerland

The European respiratory journal, 1999-02, Vol.13 (2), p.281-286

1999

Volltextzugriff (PDF)

Balancing costs and benefits in cancer therapy and prevention

Annals of oncology, 2008-09, Vol.19 (suppl-7), p.vii313-vii319

2008

Volltextzugriff (PDF)

Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription

Infection, 2003-12, Vol.31 (6), p.398-403

2003

Volltextzugriff (PDF)

Comparison of resource utilization and long-term quality-of-life outcomes between laparoscopic and conventional colorectal surgery

Surgical endoscopy, 2004-11, Vol.18 (11), p.1663-1667

2004

Volltextzugriff (PDF)

Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel

Breast cancer research and treatment, 2014-10, Vol.147 (3), p.557-570

2014

Volltextzugriff (PDF)

Pharmaco-economic aspects of lipid-lowering therapy : is it worth the price?

European heart journal, 1998-10, Vol.19, p.22-28

SZUCS, T. D

1998

Volltextzugriff (PDF)

Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05

Infection, 2007-10, Vol.35 (5), p.308-319

2007

Volltextzugriff (PDF)

Economic assessment of tirofiban in the management of acute coronary syndromes in the hospital setting; an analysis based on the PRISM PLUS trial

European heart journal, 1999-09, Vol.20 (17), p.1253-1260

1999

Volltextzugriff (PDF)

Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD)

Annals of hematology, 2015-03, Vol.94 (3), p.421-429

2015

Volltextzugriff (PDF)

Determinants of costs and resource utilization associated with open heart surgery

European heart journal, 2002-04, Vol.23 (7), p.574-578

2002

Volltextzugriff (PDF)

Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

European journal of cancer (1990), 1998-11, Vol.34 (12), p.1894-1901

1998

Volltextzugriff (PDF)

Pharmaco-economic aspects of in-vitro fertilization in Italy

Human reproduction (Oxford), 1999-04, Vol.14 (4), p.953-958

1999

Volltextzugriff (PDF)

Economic and Social Impact of Epidemic and Pandemic Influenza

Vaccine, 2006-11, Vol.24 (44), p.6776-6778

2006

Volltextzugriff (PDF)

Socioeconomic impact of haemophilia care: results of a pilot study

Haemophilia : the official journal of the World Federation of Hemophilia, 1996-10, Vol.2 (4), p.211-217

1996

Volltextzugriff (PDF)

Health economic research on vaccinations and immunisation practices—an introductory primer

Vaccine, 2005-03, Vol.23 (17), p.2095-2103

Szucs, Thomas D.

2005

Volltextzugriff (PDF)

THE COST-EFFECTIVENESS OF LOW-MOLECULAR-WEIGHT HEPARIN VS UNFRACTIONATED HEPARIN IN GENERAL AND ORTHOPAEDIC SURGERY: AN ANALYSIS FOR THE GERMAN HEALTHCARE SYSTEM

Pharmacological research, 1999-07, Vol.40 (1), p.83-89

1999

Volltextzugriff (PDF)

Cost‐effectiveness studies in ovarian cancer

International journal of gynecological cancer, 2003-11, Vol.13 (s2), p.212-219

2003

Volltextzugriff (PDF)

1 – 25 von 771

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(648)
Mit Volltextzugriff
(636)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Personalized cancer medicine and the future of pathology

Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons

Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial

Trastuzumab beyond progression: a cost-utility analysis

Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective

Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review

Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients with Cancer- or Chemotherapy-Induced Anemia

Pharmacogenetic information in Swiss drug labels - a systematic analysis

The economic burden of asthma: direct and indirect costs in Switzerland

Balancing costs and benefits in cancer therapy and prevention

Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription

Comparison of resource utilization and long-term quality-of-life outcomes between laparoscopic and conventional colorectal surgery

Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel

Pharmaco-economic aspects of lipid-lowering therapy : is it worth the price?

Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05

Economic assessment of tirofiban in the management of acute coronary syndromes in the hospital setting; an analysis based on the PRISM PLUS trial

Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD)

Determinants of costs and resource utilization associated with open heart surgery

Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

Pharmaco-economic aspects of in-vitro fertilization in Italy

Economic and Social Impact of Epidemic and Pandemic Influenza

Socioeconomic impact of haemophilia care: results of a pilot study

Health economic research on vaccinations and immunisation practices—an introductory primer

THE COST-EFFECTIVENESS OF LOW-MOLECULAR-WEIGHT HEPARIN VS UNFRACTIONATED HEPARIN IN GENERAL AND ORTHOPAEDIC SURGERY: AN ANALYSIS FOR THE GERMAN HEALTHCARE SYSTEM

Cost‐effectiveness studies in ovarian cancer

Suchergebnisse filtern